CANCER IMMUNOTHERAPY AND DRUG DISPOSITION

被引:14
作者
MULLEN, PW [1 ]
机构
[1] UNIV MANCHESTER,DEPT PHARMACOL MATERIA MED & THERAPEUT,MANCHESTER M13 9PT,ENGLAND
关键词
D O I
10.1111/j.1365-2125.1977.tb00435.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:695 / 698
页数:4
相关论文
共 37 条
  • [1] AMERY WK, 1976, CANCER TREAT REP, V60, P217
  • [2] BAST RC, 1976, CANCER RES, V36, P1967
  • [3] BECK FJ, 1974, P SOC EXP BIOL MED, V145, P135
  • [4] BECK WT, 1975, CANCER RES, V35, P1333
  • [5] BOBER LA, 1976, CANCER RES, V36, P927
  • [6] BURNET FM, 1970, PROG EXP TUMOR RES, V13, P1
  • [7] IMMUNOLOGICAL ASPECTS OF HOST-RESISTANCE TO DEVELOPMENT AND GROWTH OF CANCER
    CURRIE, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 458 (02) : 135 - 165
  • [8] INHIBITION OF DRUG-METABOLIZING-ENZYMES IN RAT AFTER BACILLUS CALMETTE-GUERIN TREATMENT
    FARQUHAR, D
    LOO, TL
    GUTTERMAN, JU
    HERSH, EM
    LUNA, MA
    [J]. BIOCHEMICAL PHARMACOLOGY, 1976, 25 (13) : 1529 - 1535
  • [9] GORODISCHER R, 1976, Biochemical Pharmacology, V25, P351, DOI 10.1016/0006-2952(76)90226-4
  • [10] GOVIER WC, 1965, J PHARMACOL EXP THER, V150, P305